Mitochondrial fragmentation in neurodegeneration
- PMID:18568013
- PMCID: PMC2711514
- DOI: 10.1038/nrn2417
Mitochondrial fragmentation in neurodegeneration
Abstract
Mitochondria are remarkably dynamic organelles that migrate, divide and fuse. Cycles of mitochondrial fission and fusion ensure metabolite and mitochondrial DNA mixing and dictate organelle shape, number and bioenergetic functionality. There is mounting evidence that mitochondrial dysfunction is an early and causal event in neurodegeneration. Mutations in the mitochondrial fusion GTPases mitofusin 2 and optic atrophy 1, neurotoxins and oxidative stress all disrupt the cable-like morphology of functional mitochondria. This results in impaired bioenergetics and mitochondrial migration, and can trigger neurodegeneration. These findings suggest potential new treatment avenues for neurodegenerative diseases.
Figures





Similar articles
- Role of mitofusin 2 in cardiovascular oxidative injury.Zheng M, Xiao RP.Zheng M, et al.J Mol Med (Berl). 2010 Oct;88(10):987-91. doi: 10.1007/s00109-010-0675-5. Epub 2010 Sep 8.J Mol Med (Berl). 2010.PMID:20824264Review.
- Less than perfect divorces: dysregulated mitochondrial fission and neurodegeneration.Oettinghaus B, Licci M, Scorrano L, Frank S.Oettinghaus B, et al.Acta Neuropathol. 2012 Feb;123(2):189-203. doi: 10.1007/s00401-011-0930-z. Epub 2011 Dec 17.Acta Neuropathol. 2012.PMID:22179580Review.
- Mitochondrial fusion proteins: dual regulators of morphology and metabolism.Zorzano A, Liesa M, Sebastián D, Segalés J, Palacín M.Zorzano A, et al.Semin Cell Dev Biol. 2010 Aug;21(6):566-74. doi: 10.1016/j.semcdb.2010.01.002. Epub 2010 Jan 15.Semin Cell Dev Biol. 2010.PMID:20079867Review.
- Loss of prohibitin membrane scaffolds impairs mitochondrial architecture and leads to tau hyperphosphorylation and neurodegeneration.Merkwirth C, Martinelli P, Korwitz A, Morbin M, Brönneke HS, Jordan SD, Rugarli EI, Langer T.Merkwirth C, et al.PLoS Genet. 2012;8(11):e1003021. doi: 10.1371/journal.pgen.1003021. Epub 2012 Nov 8.PLoS Genet. 2012.PMID:23144624Free PMC article.
- Mitochondrial involvement in neurodegenerative diseases.Zsurka G, Kunz WS.Zsurka G, et al.IUBMB Life. 2013 Mar;65(3):263-72. doi: 10.1002/iub.1126. Epub 2013 Jan 22.IUBMB Life. 2013.PMID:23341346Review.
Cited by
- Adaptive downregulation of mitochondrial function in down syndrome.Helguera P, Seiglie J, Rodriguez J, Hanna M, Helguera G, Busciglio J.Helguera P, et al.Cell Metab. 2013 Jan 8;17(1):132-40. doi: 10.1016/j.cmet.2012.12.005.Cell Metab. 2013.PMID:23312288Free PMC article.
- Regulation of mitochondrial dynamics: convergences and divergences between yeast and vertebrates.Zhao J, Lendahl U, Nistér M.Zhao J, et al.Cell Mol Life Sci. 2013 Mar;70(6):951-76. doi: 10.1007/s00018-012-1066-6. Epub 2012 Jul 18.Cell Mol Life Sci. 2013.PMID:22806564Free PMC article.Review.
- FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure.Hino S, Sakamoto A, Nagaoka K, Anan K, Wang Y, Mimasu S, Umehara T, Yokoyama S, Kosai K, Nakao M.Hino S, et al.Nat Commun. 2012 Mar 27;3:758. doi: 10.1038/ncomms1755.Nat Commun. 2012.PMID:22453831Free PMC article.
- Small but Mighty-Exosomes, Novel Intercellular Messengers in Neurodegeneration.Kumari M, Anji A.Kumari M, et al.Biology (Basel). 2022 Mar 8;11(3):413. doi: 10.3390/biology11030413.Biology (Basel). 2022.PMID:35336787Free PMC article.Review.
- The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer's disease.Kim DK, Mook-Jung I.Kim DK, et al.BMB Rep. 2019 Dec;52(12):679-688. doi: 10.5483/BMBRep.2019.52.12.282.BMB Rep. 2019.PMID:31722781Free PMC article.Review.
References
- Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell. 2006;125:1241–52. - PubMed
- Hoppins S, Lackner L, Nunnari J. The machines that divide and fuse mitochondria. Annu Rev Biochem. 2007;76:751–80. - PubMed
- Chen H, McCaffery JM, Chan DC. Mitochondrial Fusion Protects against Neurodegeneration in the Cerebellum. Cell. 2007;130:548–62. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
- R01 NS047456-01/NS/NINDS NIH HHS/United States
- R01 NS055193/NS/NINDS NIH HHS/United States
- R01 EY016164-03/EY/NEI NIH HHS/United States
- P42 ES010337-09/ES/NIEHS NIH HHS/United States
- P42 ES010337/ES/NIEHS NIH HHS/United States
- R01 NS055193-02/NS/NINDS NIH HHS/United States
- R01 EY016164-04/EY/NEI NIH HHS/United States
- P41 RR004050/RR/NCRR NIH HHS/United States
- R01 NS047456-04/NS/NINDS NIH HHS/United States
- R01 EY016164-05/EY/NEI NIH HHS/United States
- R01 EY016164-02/EY/NEI NIH HHS/United States
- R01 NS047456/NS/NINDS NIH HHS/United States
- R01 NS047456-03/NS/NINDS NIH HHS/United States
- R01 EY016164-01/EY/NEI NIH HHS/United States
- P41 RR004050-208517/RR/NCRR NIH HHS/United States
- R01 NS047456-03S1/NS/NINDS NIH HHS/United States
- R01 NS047456-02/NS/NINDS NIH HHS/United States
- R01 EY016164/EY/NEI NIH HHS/United States
- R01 NS047456-01S1/NS/NINDS NIH HHS/United States
- R01 NS047456-05/NS/NINDS NIH HHS/United States
- R01 NS055193-01A2/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical